Controversial Alzheimer's Drug Abandoned

Are you or a loved one currently taking or thinking of trying Aducanumab?

If so, this article is for you.

The FDA advisory committee voted against data from the reported Biogen drug trials as positive results were seen when the twin drugs were taken together.

Furthermore, in 2022 investigations made by congress found that the FDA broke its review and approval protocol by “inappropriately collaborating with Biogen on briefing documents, holding unreported meetings, and failing to gain internal consensus before engaging in these collaborations.”

Click on the picture above or the “Learn More” button below to read this short article as written by Judy George, Deputy Managing Editor, MedPage Today January 31, 2024.